Please assess the completion status of the following clinical trial:

Trial Title: Acute Kidney Injury After Cardiac Surgery

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: PREVENTION
- Time Perspective: None
- Masking: TRIPLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Has signed and dated the EC approved informed consent~* Subject is ≥ 18 years of age~* Requires elective or urgent (non-emergency) cardiac procedure requiring the use of ECC.~* Preoperative Acute kidney injury risk score ≥30%, found at http://cardiacsurgeryleicester.com/our-research/acute-kidney-injury-risk-score-calculator/~Exclusion Criteria:~* Unable to give informed consent~* Known bleeding disorder~* Known intolerance or contraindication to dextran~* Acute Surgery (requires emergency cardiac procedure/surgery)~* Currently using an antithrombotic medication which has not been discontinued per institution protocol~* Malignancy; Surgery within 5 years or ongoing antitumoral treatment~* Has ongoing sepsis or endocarditis~* Requires pre-operative dialysis

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Colloid priming solution for ECC circuit (Type: EXPERIMENTAL): Priming of ECC circuit with approximately 1200 mL PrimECC.
- Standard priming solution for ECC circuit (Type: ACTIVE_COMPARATOR): Priming of ECC circuit with approximately 1200 mL standard priming solution (crystalloid solution with or without mannitol addition as per routine of the participating clinic).

Based on this trial design, predict the completion outcome and termination type (if applicable).